XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Current Assets    
Cash and cash equivalents $ 8,076 $ 7,965
Short-term investments 722 899
Accounts receivable (net of allowance for doubtful accounts of $116 in 2019 and $119 in 2018) 7,608 7,071
Inventories (excludes inventories of $1,398 in 2019 and $1,417 in 2018 classified in Other assets - see Note 6) 5,712 5,440
Other current assets 3,233 4,500
Total current assets 25,351 25,875
Investments 5,621 6,233
Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,623 in 2019 and $16,324 in 2018 13,506 13,291
Goodwill 18,170 18,253
Other Intangibles, Net 10,999 11,431
Other Assets 8,707 7,554
Total Assets 82,354 82,637
Current Liabilities    
Loans payable and current portion of long-term debt 3,175 5,308
Trade accounts payable 3,018 3,318
Accrued and other current liabilities 10,081 10,151
Income taxes payable 807 1,971
Dividends payable 1,462 1,458
Total current liabilities 18,543 22,206
Long-Term Debt 22,721 19,806
Deferred Income Taxes 1,835 1,702
Other Noncurrent Liabilities 11,585 12,041
Merck & Co., Inc. Stockholders’ Equity    
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2019 and 2018 1,788 1,788
Other paid-in capital 38,768 38,808
Retained earnings 44,065 42,579
Accumulated other comprehensive loss (5,346) (5,545)
Stockholders' equity before deduction for treasury stock 79,275 77,630
Less treasury stock, at cost: 994,032,308 shares in 2019 and 984,543,979 shares in 2018 51,736 50,929
Total Merck & Co., Inc. stockholders’ equity 27,539 26,701
Noncontrolling Interests 131 181
Total equity 27,670 26,882
Liabilities and Equity $ 82,354 $ 82,637